What is Mohawk Valley Retina?
Established in 1997, Mohawk Valley Retina operates as a premier medical practice dedicated to the diagnosis and treatment of complex vitreo-retinal disorders, glaucoma, and ocular inflammation. The firm distinguishes itself through a commitment to high-quality care, utilizing state-of-the-art diagnostic and therapeutic equipment to serve the Central New York region. With a team of board-certified ophthalmologists, the practice provides a comprehensive suite of services, ranging from advanced injection therapy and laser treatments to complex surgical interventions. Their market position is defined by a dual focus on clinical excellence and compassionate patient outcomes, ensuring they remain a critical provider for both routine and emergency ophthalmic needs.
How much funding has Mohawk Valley Retina raised?
Mohawk Valley Retina has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Mohawk Valley Retina
PPP
Public-Private Partnership
What's next for Mohawk Valley Retina?
With the recent infusion of capital, Mohawk Valley Retina is well-positioned to scale its service offerings and invest in next-generation medical technology. The strategic roadmap likely involves expanding its diagnostic infrastructure to accommodate the growing demand for specialized eye care in the Central New York area. By prioritizing the integration of innovative therapeutic modalities, the practice is set to enhance its operational efficiency and patient throughput. This late-stage financing serves as a catalyst for long-term sustainability, allowing the firm to maintain its competitive edge while continuing to provide essential, high-acuity medical services to its patient base.
See full Mohawk Valley Retina company page
